Ono Pharmaceutical CoTSE:4528 +0.71%89 Days Payable is 174.23 as of Mar. 2026, which is 2% below its 10-year median of 177.30. GuruFocus rates TSE:4528 with a GF Score™ of 89/100 and a GF Value™ of 円2,245.98 (Fairly Valued). The stock has 4 warning signs investors should review. Among 919 Drug Manufacturers companies, Ono Pharmaceutical Co ranks better than 80.96% on this metric.
Ono Pharmaceutical Co Days Payable Historical Data
* Premium members only.
The historical data trend for Ono Pharmaceutical Co's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:4528 vs LLY, JNJ, ABBV: Days Payable Comparison
For the Drug Manufacturers - General subindustry, Ono Pharmaceutical Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ono Pharmaceutical Co Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Ono Pharmaceutical Co's Days Payable distribution charts can be found below:
* The bar in red indicates where Ono Pharmaceutical Co's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Ono Pharmaceutical Co's Days Payable for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ono Pharmaceutical Co (TSE:4528) has a Days Payable of 174.23 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Ono Pharmaceutical Co and its competitors. This is near median its historical median of 177.30. Over the past decade, Ono Pharmaceutical Co's Days Payable has ranged from 154.24 to 196.10. According to the industry distribution chart, Ono Pharmaceutical Co ranks #175 out of 919 companies in the Drug Manufacturers industry, placing it in the top 19%.
Is Ono Pharmaceutical Co's Days Payable too high?
Ono Pharmaceutical Co's current Days Payable of 174.23 is near median its 10-year median of 177.30. Over the past 10 years, this metric has ranged from a low of 154.24 to a high of 196.10. The Drug Manufacturers industry median Days Payable is 90.69. Ono Pharmaceutical Co's value of 174.23 is 92.1% above this industry median. Based on the distribution chart, Ono Pharmaceutical Co ranks #175 out of 919 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Ono Pharmaceutical Co has a GF Score™ of 89/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Ono Pharmaceutical Co's Days Payable compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Ono Pharmaceutical Co ranks #175 out of 919 companies for Days Payable. This places Ono Pharmaceutical Co in the top 19% of its industry — outperforming the majority of peers. The industry median Days Payable is 90.69. Ono Pharmaceutical Co's value of 174.23 is 92.1% above this benchmark. Historically, Ono Pharmaceutical Co's own Days Payable has ranged from 154.24 to 196.10 over the past decade. While the company's 10-year median is 177.30 vs. the industry median of 90.69, Ono Pharmaceutical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.69, based on 919 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ono Pharmaceutical Co's current Days Payable of 174.23 is 92.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Ono Pharmaceutical Co and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.69 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ono Pharmaceutical Co's current Days Payable is 174.23, which is near median its own 10-year median of 177.30. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ono Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Ono Pharmaceutical Co (TSE:4528) is currently considered Fairly Valued. The stock's GF Value™ is 円2,245.98, compared to a current price of 円2,419.00 — trading 7.7% above its estimated fair value. The current Days Payable is 174.23, which is near median its 10-year median of 177.30 and 92.1% above the Drug Manufacturers industry median of 90.69. Ono Pharmaceutical Co's overall GF Score™ is 89/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Ono Pharmaceutical Co (TSE:4528), the current Days Payable is 174.23 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ono Pharmaceutical Co (TSE:4528) Overvalued in 2026?
Based on GuruFocus' analysis, Ono Pharmaceutical Co stock appears to be overvalued.
The current stock price of 円2,419.00 is trading 7.7% above its estimated GF Value™ of 円2,245.98.
GuruFocus considers Ono Pharmaceutical Co to be Fairly Valued.
Key valuation signals for TSE:4528:
Days Payable: 174.23 (near median its 10-year median of 177.30)
GF Value™: 円2,245.98 vs. price of 円2,419.00 (7.7% above fair value)
Industry Position: 92.1% above the Drug Manufacturers median (#175 of 919)
No single metric tells the full story. See the TSE:4528 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ono Pharmaceutical Co Ltd is a drug manufacturer with a focus on drug discovery in areas of unmet medical needs. The vast majority of the company's revenue is derived from its circulatory and respiratory drugs, followed by its metabolic drugs and vitamins. The company also reports revenue derived from royalties. The bulk of the company's sales is generated in Japan, followed by the rest of Asia and Europe.
89GF Score
Get the complete analysis for TSE:4528
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4528 has been successfully added to your 
